Sierra Oncology, Inc. (SRRA) earnings
Quarterly and annual SRRA reports and results, each read against the price at its own news timestamp. Back to the SRRA overview →
No SRRA earnings events in the measured window.
Nothing matched in the current window — the SRRA overview has every event we measure for this name.
Get an email when SRRA moves on news →Keep exploring
More SRRA: analyst actions → · SEC filings → · SRRA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Kindred Biosciences, Inc. (KIN) | 650 | 0.00% | 46% |
| Otonomy, Inc. (OTIC) | 649 | 0.00% | 48% |
| Catabasis Pharmaceuticals, Inc. (CATB) | 647 | -0.14% | 45% |
| Bristol-Myers Squibb Company (BMY) | 642 | -0.02% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.